Literature DB >> 19428625

Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.

Timothy P O'Leary1, Richard E Brown.   

Abstract

The APPswe/PS1dE9 mouse is a double transgenic model of Alzheimer's disease, which harbors mutant mouse/human amyloid precursor protein (Swedish K594N/M595L) and presenilin-1 genes (PS1-dE9). These mice develop beta-amyloid plaques and exhibit visuo-spatial learning and memory impairment in the Morris water maze (MWM) at 8-12 and 16-18 months of age. To extend these findings, we tested visuo-spatial learning and memory of male and female APPswe/PS1dE9 mice at 16 months of age on the Barnes maze. APPswe/PS1dE9 mice showed impaired acquisition learning using measures of latency, distance traveled, errors and hole deviation scores, and were less likely to use the spatial search strategy to locate the escape hole than wild-type mice. APPswe/PS1dE9 mice also showed a deficit in memory in probe tests on the Barnes maze relative to wild-type mice. Learning and memory deficits, however, were not found during reversal training and reversal probe tests. Sex differences were observed, as male APPswe/PS1dE9 mice had smaller reversal effects than male wild-type mice, but females of each genotype did not differ. Overall, these results replicate previous findings using the MWM, and indicate that APPswe/PS1dE9 mice have impaired visuo-spatial learning and memory at 16 months of age.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428625     DOI: 10.1016/j.bbr.2009.01.039

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  43 in total

1.  Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers.

Authors:  Sam Gandy; Adam J Simon; John W Steele; Alex L Lublin; James J Lah; Lary C Walker; Allan I Levey; Grant A Krafft; Efrat Levy; Frédéric Checler; Charles Glabe; Warren B Bilker; Ted Abel; James Schmeidler; Michelle E Ehrlich
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

2.  Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.

Authors:  Huang Huang; Sipei Nie; Min Cao; Charles Marshall; Junying Gao; Na Xiao; Gang Hu; Ming Xiao
Journal:  Age (Dordr)       Date:  2016-07-21

3.  Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Catherine E Sykes; Mrudang M Shah; Dina M Francescutti; David R Rosenberg; David M Thomas; Donald M Kuhn
Journal:  J Neurochem       Date:  2012-04-13       Impact factor: 5.372

4.  Barnes maze testing strategies with small and large rodent models.

Authors:  Cheryl S Rosenfeld; Sherry A Ferguson
Journal:  J Vis Exp       Date:  2014-02-26       Impact factor: 1.355

5.  APOE3, but not APOE4, bone marrow transplantation mitigates behavioral and pathological changes in a mouse model of Alzheimer disease.

Authors:  Yue Yang; Eiron Cudaback; Nikolas L Jorstad; Jake F Hemingway; Catherine E Hagan; Erica J Melief; Xianwu Li; Tom Yoo; Shawn B Khademi; Kathleen S Montine; Thomas J Montine; C Dirk Keene
Journal:  Am J Pathol       Date:  2013-07-04       Impact factor: 4.307

6.  Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease.

Authors:  Sultan Darvesh; Meghan K Cash; George Andrew Reid; Earl Martin; Arnold Mitnitski; Changiz Geula
Journal:  J Neuropathol Exp Neurol       Date:  2012-01       Impact factor: 3.685

7.  Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.

Authors:  Kenneth E Bernstein; Yosef Koronyo; Brenda C Salumbides; Julia Sheyn; Lindsey Pelissier; Dahabada H J Lopes; Kandarp H Shah; Ellen A Bernstein; Dieu-Trang Fuchs; Jeff J-Y Yu; Michael Pham; Keith L Black; Xiao Z Shen; Sebastien Fuchs; Maya Koronyo-Hamaoui
Journal:  J Clin Invest       Date:  2014-03       Impact factor: 14.808

8.  BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease.

Authors:  Rebecca M Burke; Timothy A Norman; Tarik F Haydar; Barbara E Slack; Susan E Leeman; Jan Krzysztof Blusztajn; Tiffany J Mellott
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

9.  Predictably irrational: assaying cognitive inflexibility in mouse models of schizophrenia.

Authors:  Jonathan L Brigman; Carolyn Graybeal; Andrew Holmes
Journal:  Front Neurosci       Date:  2010-05-15       Impact factor: 4.677

10.  Anesthetic Isoflurane or Desflurane Plus Surgery Differently Affects Cognitive Function in Alzheimer's Disease Transgenic Mice.

Authors:  Huihui Miao; Yuanlin Dong; Yiying Zhang; Hui Zheng; Yuan Shen; Gregory Crosby; Deborah J Culley; Edward R Marcantonio; Zhongcong Xie
Journal:  Mol Neurobiol       Date:  2017-10-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.